Supports research identified by the international Linked Clinical Trials committee as essential before Parkinson's therapies can proceed to clinical trials. Funded activities include pre-clinical research, epidemiological studies, dose finding, and target engagement research to accelerate therapy development.
Eligibility criteria are not specified for this funding opportunity.
